header-image

GDP Forum 2025

25/26 June 2025, Barcelona, Spain

Seminar-Nr. 21726

Referent:innen

Alfred Hunt

Alfred Hunt

Hunt Pharma Solutions

Emil Schwan

Emil Schwan

Swedish Medical Products Agency

Dr. Sue Mann

Dr. Sue Mann

Sue Mann Consultancy

Dr Daniel Müller

Dr Daniel Müller

GMP Inspector

Dr Torsten Schmidt-Bader

Dr Torsten Schmidt-Bader

moveproTEC Compliance & Innovation Advisory

Dr Zvonimir Majic

Dr Zvonimir Majic

IATA Senior consultant for Healthcare, Croatia

Robert Kayum

Robert Kayum

DD, UK

Tina Geyer

Tina Geyer

Hintergrund

Dear Colleagues,

I am pleased to invite you to the European GMP & GDP Forum, taking place from 24-26 June 2025 in Barcelona, Spain.

As many of you know, our ECA members have enjoyed biannual conferences dedicated to GMP and GDP for several years. Since 2021, we have combined these two into a unique event, bringing together the European GMP Conference and the European GDP Forum.

This three-day event is designed to provide flexibility and focus:
  • The first 1½ days are dedicated to Good Manufacturing Practice (GMP), offering expert presentations, regulatory updates, and discussions on emerging trends and practical implementations.
  • The second 1½ days will center on Good Distribution Practice (GDP), covering the latest developments and best practices in this area.
This flexible format allows you to tailor your participation according to your specific interests and needs. You may choose to attend only the GMP Forum, only the GDP Forum, or all three days of the event.

For our third Forum in June 2025 we have invited speakers from Regulatory Authorities, leading Organisations and the Pharmaceutical Industry to share and discuss with you the latest GMP & GDP developments.

I look forward to welcoming you to this event – on-site in Barcelona!

Yours sincerely,
Dr Afshin Hosseiny, Chairman of the ECA Advisory Board

Zielgruppe

The conference is of particular interest for GMP experts of pharmaceutical companies (e.g. QA, QC, production, regulatory affairs), of GMP inspectorates and Regulatory Authorities. It is also of interest for all personnel involved in GDP – pharmaceutical storage, transportation, cold chain and distribution activities and the control of these activities.

Programm

GDP Forum 2025

Gesamtes Programm als PDF herunterladen

Agenda – Day 2 (afternoon): GDP Forum, 25 June 2025

GDP Update & Outlook
Alfred Hunt
  • Major GDP developments of the last few months
  • Current trends in Europe and the US
  • Outlook for 2025/2026
GDP Inspection Findings and Recent Trends Emil Schwan
  • Inspections of the competent authorities
  • Typical GDP inspection findings
Managing a GDP Inspection to Maximise the Chance of Success
Sue Mann
  • Importance of careful planning for a GDP inspection
  • Specific roles throughout the inspection
  • How to ensure the regulatory authority accepts your responses
Human and veterinary GDP regulations within the EU - are they really the same?
Dr Daniel Müller
  • Regulatory framework for GDP
  • Current relevant guidelines on GDP
  • Similarities and differences, pitfalls
  • Inspection focus
Resilience in the Pharma Supply Chain
Dr Martin Egger
  • Current disruptions in the global supply chain and their effects
  • Recommendations of the EMA to strengthen the supply chain of critical medicinal products
  • Mitigation measures in the supply chain
GDP Challenges and Solutions in Ukraine’s War-Torn Supply Chain
Oleksandra Bakhurynska
  • BCP plan and reality
  • Challenges in maintaining quality Standards
  • Solutions and changed approaches
Agenda – Day 3: GDP Forum, 26 June 2025

Distribution Control – the magic of KPI, QPI and management dashboards for reliable GDP transports
Dr Torsten Schmidt-Bader
  • Reliable pharma transports - what is wrong with global distribution?
  • The world is not „GDP perfect“ - how to prepare for the worst
  • Transport performance - no data, no Control
  • KPI, QPI and dashboards - 5 critical process Parameters
  • Feedback & feedforward - how to implement risk principles into Transportation
  • Distribution control: The unknown management task in quality systems
Pharma and Healthcare Shipment Transported by Air: CEIV Pharma Certification
Mateusz Zawadzki
  • IATA Temperature Control Regulations (TCR): Governance structure, regulatory context and upcoming key changes
  • CEIV Pharma Program: certification scope and criteria, assessment process and upcoming enhancements
Application of AI in Modelling Logistics Solution for Frozen Drug Substance Airfreight Transport
Dr Zvonimir Majic
  • Introduction to airfreight deep frozen capabilities and solutions: Regulations beyond GDP
  • Specific requirements for deep frozen APIs transported in airfreight
  • The use of AI in risk-based route risk assessment for deep frozen APIs
  • Airfreight route modeling and qualification under Deep frozen conditions
  • Ethical considerations in use of AI in pharma-airfreight
Revolutionizing Quality Assurance through Automation – The Future of GDP
Michael Fleischer
  • The early days of GDP – GDP Compliance in the early days
  • Increased complexity in GDP – The dynamics of specialized products and therapies lead to a new mindset
  • Evolution of GDP to digital – The rise of Robotic
Process Automation
  • Regulatory Considerations – Software qualification and validation of computerised systems
Innovation in Pharmaceutical Quality Assurance – Enhancing Compliance and Efficiency
Robert Kayum
  • IT based Solutions
  • Continuous improvement trends – Airlines & Logistics Partners
  • Temperature Control Packaging & Supply Chain Visibility
  • Optimising your supply chain through reverse logistics and reusable temperature control packaging – passive and hybrid
The Global Cold Chain Puzzle: Ensuring Compliance for Cold Chain Transportation
Tina Geyer
  • Unraveling the GDP Maze: Understanding Global GDP Standards for cold chain Transportation
  • Transportation: Active and passive systems
BUSINESS USE CASE: Setting up a Logistics Network Hub – to enable Sea-Freight
Saddam Huq
  • Optimize Logistics Network Design
  • Selection and Assessment Criteria
  • Proof of concept and Target model

ECA-Member*: € 1490,-
Non ECA Member*: € 1690,-
EU/GMP Inspectorates*: € 845,-
APIC Member Discount*: € 1590,-
GDP Association Member Discount*: € 1490,-

Alle Preise zzgl. MwSt. Wichtige Hinweise zur Umsatzsteuer.

* auch unkompliziert per Kreditkarte bezahlbar
American Express Visa Mastercard

icon
Weitere Termine vor Ort
Weitere Termine vor Ort nicht verfügbar
icon
Weitere Termine online
Weitere Termine online nicht verfügbar
icon
Aufzeichnung nicht verfügbar

Haben Sie noch Fragen?

Wir stehen Ihnen für weitere Auskünfte gerne zur Verfügung.
Tel.: +49 6221 84 44 0
E-Mail: info@concept-heidelberg.de

Frau mit Headset

Zurück

Teilnehmerstimmen - das sagen andere über unsere Seminare:

Guter, breit gefächerter Überblick mit interessanten Verknüpfungen zur Praxis,
welche die Theorie super veranschaulicht.”
Marina Kicoranovic, Labor Hartmann GmbH
GMP/Basis-Einstiegsschulung (B 14), September 2023

Die Referenten waren sehr gut! Sie haben sehr klar gesprochen, nur sehr wenige englische Begriffe
verwendet (super) und waren sehr praxisbezogen.”
Astrid Gießler, Regierungspräsidium Karlsruhe
Live Online Seminar - Basiskurs Computervalidierung & Datenintegrität im GxP Umfeld (B 3), Juni 2023

Sehr guter Bezug zur Schulung für einen GMP-Anfänger. Habe mich sehr gut abgeholt gefühlt.”
Dr. Harald Werner, Infraserv GmbH & Co. Höchst KG
GMP-Basisschulung (B 1), Juni 2023

Wichtiger Hinweis

Aufgrund unserer Betriebsferien können zwischen dem 23.12.2024 und dem 01.01.2025 keine Registrierungen bearbeitet werden.

Danke für Ihr Verständnis.

Das Team von CONCEPT HEIDELBERG